FGEN stock forecast
Our latest prediction for FibroGen, Inc.'s stock price was made on the Sept. 17, 2019 when the stock price was at 41.41$.
In the short term (2weeks), FGEN's stock price should outperform the market by 1.61%. During that period the price should oscillate between -5.85% and +7.65%.
In the medium term (3months), FGEN's stock price should outperform the market by 4.79%. During that period the price should oscillate between -14.21% and +24.03%.Get email alerts
About FibroGen, Inc.
FibroGen, Inc. engages in the discovery, development, and commercialization of therapeutics. It focuses on hypoxia-inducible factor and connective tissue growth factor biology to develop innovative medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993 and is headquartered in San Francisco, CA.
At the moment the company generates 357M USD in revenues.
On its last earning announcement, the company reported a profit of 0.48$ per share.
The book value per share is 5.88$
Three months stock forecastSept. 17, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|